This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: Novartis Ag. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations by Inventor Fritz Andreae
Introduction
Fritz Andreae is a notable inventor based in Raaba-Grambach, Austria. He has made significant contributions to the field of medical science, particularly in the synthesis of ligands that target prostate-specific membrane antigens (PSMA). His work is crucial in the ongoing fight against diseases such as cancer.
Latest Patents
Fritz Andreae holds a patent for the "Synthesis of prostate specific membrane antigen (PSMA) ligands." This patent details a method for synthesizing PSMA ligands that incorporate a glutamate-urea-lysine (GUL) moiety along with a chelating agent that can include a radiometal. This innovation is pivotal for developing targeted therapies for cancer treatment.
Career Highlights
Fritz Andreae is associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field, further enhancing the impact of his inventions.
Conclusion
Fritz Andreae's contributions to the synthesis of PSMA ligands represent a significant advancement in cancer treatment. His innovative approach and dedication to medical science continue to inspire future research and development in this critical area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile